首页> 美国卫生研究院文献>International Journal of Neuropsychopharmacology >A Study in First-Episode Psychosis Patients: Does Angiotensin I-Converting Enzyme Activity Associated With Genotype Predict Symptom Severity Reductions After Treatment With Atypical Antipsychotic Risperidone?

【2h】

A Study in First-Episode Psychosis Patients: Does Angiotensin I-Converting Enzyme Activity Associated With Genotype Predict Symptom Severity Reductions After Treatment With Atypical Antipsychotic Risperidone?

机译：第一集发作性能患者的研究：血管紧张素I-转换酶活性与基因型相关的酶活性预测非典型抗精神病药酮治疗后的症状严重程度减少？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Our previous studies showed increased angiotensin I-converting enzyme (ACE) activity in chronic schizophrenia patients compared with healthy control (HC) volunteers, and the relevance of combining ACE genotype and activity for predicting schizophrenia was suggested.

机译：我们以前的研究表明，与健康对照（HC）志愿者相比，慢性精神分裂症患者中的血管紧张素I-转换酶（ACE）活性增加，并提出了组合ACE基因型和活性来预测精神分裂症的相关性。

著录项

期刊名称 International Journal of Neuropsychopharmacology
作者
João V Nani; Caroline Dal Mas; Camila M Yonamine; Vanessa K Ota; Cristiano Noto; Sintia I Belangero; Jair J Mari; Rodrigo Bressan; Quirino Cordeiro; Ary Gadelha; Mirian A F Hayashi;
展开▼
作者单位

展开▼
年(卷),期 2020(23),11
年度 2020
页码 721–730
总页数 10
原文格式 PDF
正文语种
中图分类神经科学;药学;神经病学;精神病学;
关键词
Angiotensin-converting enzyme (ACE); first-episode psychosis (FEP); risperidone; genotype; enzyme activity;

机译：血管紧张素转换酶（ACE）;第一集精神病（FEP）;risperidone;基因型;酶活性;

相似文献

外文文献
中文文献
专利

1. A Study in First-Episode Psychosis Patients: Does Angiotensin I-Converting Enzyme Activity Associated With Genotype Predict Symptom Severity Reductions After Treatment With Atypical Antipsychotic Risperidone? [J] . Nani Jo?o V, Dal Mas Caroline, Yonamine Camila M, The international journal of neuropsychopharmacology . 2020,第11期

机译：第一集发作性能患者的研究：血管紧张素I-转换酶活性与基因型相关的酶活性，预测非典型抗精神病药酮治疗后的症状严重程度减少？
2. Predictors of the discharge dosage of an atypical antipsychotic agent among hospitalized, treatment-naive, first-episode psychosis patients in naturalistic, public-sector settings. [J] . Compton MT, Kelley ME, Lloyd RB, Journal of clinical psychopharmacology . 2011,第1期

机译：在自然的公共部门环境中，住院的，未接受过治疗的首发精神病患者中非典型抗精神病药的排出剂量的预测指标。
3. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol. [J] . Saddichha S, Ameen S, Akhtar S Journal of clinical psychopharmacology . 2008,第1期

机译：首发精神病中抗精神病药引起的体重增加的预测因素：奥氮平，利培酮和氟哌啶醇的随机，双盲，对照前瞻性研究得出的结论。
4. Reduction in Severity Symptoms Among Adult Patients with Psychosis by Psychoeducation [D] . Etukudoh, Akaninyene (Victor) J. 2021

机译：通过心理教育减少成人心理患者的严重程度症状
5. F181. CHANGE IN PREFRONTAL-LIMBIC MORPHOLOGY AND COGNITION IN DRUG-NAïVE FIRST-EPISODE PSYCHOSIS PATIENTS FOLLOWING ATYPICAL ANTIPSYCHOTIC TREATMENT: A BRIEF LONGITUDINAL STUDY [O] . Melissa Woodward, Geoffrey Smith, William Honer, 2018

机译：F181。非典型抗精神病药物治疗后未治疗的初次发作的精神分裂症患者前肢形态和认知的变化：一项简短的纵向研究
6. A Study in First-Episode Psychosis Patients: Does Angiotensin I-Converting Enzyme Activity Associated With Genotype Predict Symptom Severity Reductions After Treatment With Atypical Antipsychotic Risperidone? [O] . João V Nani, Caroline Dal Mas, Camila M Yonamine, 2020

机译：第一集发作性能患者的研究：血管紧张素I-转换酶活性与基因型相关的酶活性，预测非典型抗精神病药酮治疗后的症状严重程度减少？

A Study in First-Episode Psychosis Patients: Does Angiotensin I-Converting Enzyme Activity Associated With Genotype Predict Symptom Severity Reductions After Treatment With Atypical Antipsychotic Risperidone?

摘要

著录项

相似文献

相关主题

期刊订阅